Concord Biotech Ltd NSE:CONCORDBIO:
CONCORD BIOTECH - CFO LALIT SETHI TO RETIRE EARLY EFFECTIVE JANUARY 5, 2026
Concord Biotech Says CFO Lalit Sethi To Retire
Watch Concord Biotech's latest callConcord Biotech (NSE:CONCORDBIO) Q2 2027 Earnings Call · Replay · Oct 28Read the transcript of Concord Biotech (NSE:CONCORDBIO) Q2 2027 Earnings CallEarlier from Concord Biotech
- CONCORDBIO: Revenue and profit dipped on delays, but margins improved and recovery is expected ahead
- Concord Biotech Q2 profit slides 34%; board clears new ventures
- Music publishers fend off Anthropic's bid to dismiss some AI copyright claims
- Concord Biotech Shareholders Approve ₹1 Dividend, Re-appoint Director
- Concord Biotech dividend ex-date due tomorrow for Rs 10.7 per share payout; last day to trade today
Later from Concord Biotech
- Concord Biotech Appoints Raviraj Karia As CFO
- Bertelsmann's BMG weighs possible acquisition of Concord, Bloomberg News reports
- Mergers and acquisitions
- CONCORDBIO: Strong revenue growth and stable profits, with a one-time charge for regulatory changes
- CONCORDBIO: Q3 revenue up 14% YoY, API volumes strong, injectables and CDMO to drive future growth
Follow Concord Biotech into a list and get an email when it puts out news.
Follow Concord Biotech